{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:18:19Z","timestamp":1792801099688,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03098-z","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:08:38Z","timestamp":1771852118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce"],"prefix":"10.1186","volume":"25","author":[{"given":"Christoph","family":"Wanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Barnard-Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena N.","family":"Boll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James R.","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kellerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebojsa","family":"Lalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Nedungadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena W.","family":"Rodbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Huey-Herng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Standl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Topsever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"38","key":"3098_CR1","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"36","key":"3098_CR2","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"39","key":"3098_CR3","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Schutt K, Muller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"issue":"22","key":"3098_CR4","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","volume":"85","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2025;85(22):2135\u2013237.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"3098_CR5","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","volume":"149","author":"SR Ommen","year":"2024","unstructured":"Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, et al. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2024;149(23):e1239\u2013311.","journal-title":"Circulation"},{"key":"3098_CR6","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"2","key":"3098_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ndt\/gfae209","volume":"40","author":"F Iatridi","year":"2025","unstructured":"Iatridi F, Carrero JJ, Cornec-Le Gall E, Kanbay M, Luyckx V, Shroff R, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease in children and adults: a commentary from the European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2025;40(2):273\u201382.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"3098_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s00125-025-06370-1","volume":"68","author":"T Karagiannis","year":"2025","unstructured":"Karagiannis T, Advani A, Davies MJ, Del Prato S, Dinneen SF, Kuss O, et al. European Association for the Study of Diabetes (EASD) standard operating procedure for the development of guidelines. Diabetologia. 2025;68(8):1600\u201315.","journal-title":"Diabetologia"},{"issue":"8","key":"3098_CR9","first-page":"1276","volume":"47","author":"M Phillip","year":"2024","unstructured":"Phillip M, Achenbach P, Addala A, Albanese-O\u2019Neill A, Battelino T, Bell KJ, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care. 2024;47(8):1276\u201398.","journal-title":"Diabetes Care"},{"issue":"8","key":"3098_CR10","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024;47(8):1257\u201375.","journal-title":"Diabetes Care"},{"key":"3098_CR11","doi-asserted-by":"publisher","unstructured":"Committee ADAPP. Standards of care in diabetes\u20142025. Diabetes Care. 2024. https:\/\/doi.org\/10.2337\/dc25-in01.","DOI":"10.2337\/dc25-in01"},{"key":"3098_CR12","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) FT. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542."},{"key":"3098_CR13","doi-asserted-by":"publisher","first-page":"e082071","DOI":"10.1136\/bmj-2024-082071","volume":"390","author":"A Agarwal","year":"2025","unstructured":"Agarwal A, Mustafa R, Manja V, Agoritsas T, Macdonald H, Li S, et al. Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline. BMJ. 2025;390:e082071.","journal-title":"BMJ"},{"issue":"8","key":"3098_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/2047487318825350","volume":"26","author":"K Kotseva","year":"2019","unstructured":"Kotseva K, De Backer G, De Bacquer D, Ryd\u00e9n L, Hoes A, Grobbee D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824\u201335.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"3098_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12933-023-01840-5","volume":"22","author":"P Bramlage","year":"2023","unstructured":"Bramlage P, Lanzinger S, M\u00fchldorfer S, Milek K, Gillessen A, Veith R, et al. An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria. Cardiovasc Diabetol. 2023;22(1):108.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3098_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12913-025-12270-2","volume":"25","author":"AC Thoonsen","year":"2025","unstructured":"Thoonsen AC, Gans A, Broeders TT, van Beusekom I, Delnoij DMJ, de Bruijne MC, et al. Nationwide guideline implementation: a qualitative study of barriers and facilitators from the perspective of guideline organizations. BMC Health Serv Res. 2025;25(1):150.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"3098_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13012-021-01159-3","volume":"16","author":"M Dreger","year":"2021","unstructured":"Dreger M, Eckhardt H, Felgner S, Ermann H, Lantzsch H, Rombey T, et al. Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development. Implement Sci. 2021;16(1):94.","journal-title":"Implement Sci"},{"issue":"8","key":"3098_CR18","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1503\/cmaj.211416","volume":"194","author":"JE Squires","year":"2022","unstructured":"Squires JE, Cho-Young D, Aloisio LD, Bell R, Bornstein S, Brien SE, et al. Inappropriate use of clinical practices in Canada: a systematic review. CMAJ. 2022;194(8):E279\u201396.","journal-title":"CMAJ"},{"issue":"1","key":"3098_CR19","doi-asserted-by":"publisher","first-page":"e040961","DOI":"10.1136\/bmjopen-2020-040961","volume":"11","author":"CJ Cohen-Stavi","year":"2021","unstructured":"Cohen-Stavi CJ, Giveon S, Key C, Molcho T, Balicer R, Shadmi E. Guideline deviation and its association with specific chronic diseases among patients with multimorbidity: a cross-sectional cohort study in a care management setting. BMJ Open. 2021;11(1):e040961.","journal-title":"BMJ Open"},{"issue":"11","key":"3098_CR20","doi-asserted-by":"publisher","first-page":"sfae331","DOI":"10.1093\/ckj\/sfae331","volume":"17","author":"G Ev\u00e9n","year":"2024","unstructured":"Ev\u00e9n G, Stenfors T, Jacobson SH, Jernberg T, Franz\u00e9n-Dahlin \u00c5, J\u00e4ghult S, et al. Integrated, person-centred care for patients with complex cardiovascular disease, diabetes mellitus and chronic kidney disease: a randomized trial. Clin Kidney J. 2024;17(11):sfae331.","journal-title":"Clin Kidney J"},{"issue":"12","key":"3098_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/clc.23898","volume":"45","author":"C Chen","year":"2022","unstructured":"Chen C, Li X, Su Y, You Z, Wan R, Hong K. Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: \u201creal-world\u201d evidence. Clin Cardiol. 2022;45(12):1220\u20138.","journal-title":"Clin Cardiol"},{"issue":"5","key":"3098_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13300-025-01725-8","volume":"16","author":"E Vianini","year":"2025","unstructured":"Vianini E, Pandey A, Rolland C, Ngubane N, Mueller-Wieland D, Gilbert J, et al. Systematic literature review of the impact of type 2 diabetes and heart failure guideline adherence on clinical and economic outcomes. Diabetes Ther. 2025;16(5):851\u201364.","journal-title":"Diabetes Ther"},{"key":"3098_CR23","doi-asserted-by":"publisher","first-page":"1570359","DOI":"10.3389\/fphar.2025.1570359","volume":"16","author":"M Achterbosch","year":"2025","unstructured":"Achterbosch M, Aksoy N, Obeng GD, Ameyaw D, \u00c1gh T, van Boven JFM. Clinical and economic consequences of medication nonadherence: a review of systematic reviews. Front Pharmacol. 2025;16:1570359.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3098_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12882-017-0493-x","volume":"18","author":"C Lo","year":"2017","unstructured":"Lo C, Teede H, Fulcher G, Gallagher M, Kerr PG, Ranasinha S, et al. Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study. BMC Nephrol. 2017;18(1):80.","journal-title":"BMC Nephrol"},{"key":"3098_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-5908-6-26","volume":"6","author":"AR Gagliardi","year":"2011","unstructured":"Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6:26.","journal-title":"Implement Sci"},{"key":"3098_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1748-5908-8-35","volume":"8","author":"SA Flottorp","year":"2013","unstructured":"Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8:35.","journal-title":"Implement Sci"},{"issue":"3","key":"3098_CR27","doi-asserted-by":"publisher","first-page":"e14173","DOI":"10.1111\/jep.14173","volume":"31","author":"E Shehu","year":"2025","unstructured":"Shehu E, Kugler CM, Sch\u00e4fer N, Rosen D, Schaefer C, K\u00f6tter T, et al. Barriers and facilitators of adherence to clinical practice guidelines in Germany-A systematic review. J Eval Clin Pract. 2025;31(3):e14173.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"3098_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13012-021-01140-0","volume":"16","author":"C McArthur","year":"2021","unstructured":"McArthur C, Bai Y, Hewston P, Giangregorio L, Straus S, Papaioannou A. Barriers and facilitators to implementing evidence-based guidelines in long-term care: a qualitative evidence synthesis. Implement Sci. 2021;16(1):70.","journal-title":"Implement Sci"},{"key":"3098_CR29","doi-asserted-by":"crossref","unstructured":"Wensing M, Klauber J, Klemperer D, Nothacker M, Robra BP, Schmuker C. Implementierung klinischer Leitlinien: ein systematischer Ansatz. Versorgungs-Report Leitlinien\u2014Evidenz f\u00fcr die Praxis. 2023;MWV Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin.2023:131-8.","DOI":"10.32745\/9783954668007-11"},{"issue":"14","key":"3098_CR30","doi-asserted-by":"publisher","first-page":"E362","DOI":"10.1503\/cmaj.151102","volume":"188","author":"S Gupta","year":"2016","unstructured":"Gupta S, Rai N, Bhattacharrya O, Cheng AYY, Connelly KA, Boulet LP, et al. Optimizing the language and format of guidelines to improve guideline uptake. CMAJ. 2016;188(14):E362\u20138.","journal-title":"CMAJ"},{"issue":"1","key":"3098_CR31","doi-asserted-by":"publisher","first-page":"e062158","DOI":"10.1136\/bmjopen-2022-062158","volume":"13","author":"T Wang","year":"2023","unstructured":"Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open. 2023;13(1):e062158.","journal-title":"BMJ Open"},{"issue":"4","key":"3098_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/ANS.0000000000000263","volume":"42","author":"M Beauchemin","year":"2019","unstructured":"Beauchemin M, Cohn E, Shelton RC. Implementation of clinical practice guidelines in the health care setting: a concept analysis. ANS Adv Nurs Sci. 2019;42(4):307\u201324.","journal-title":"ANS Adv Nurs Sci"},{"issue":"2","key":"3098_CR33","doi-asserted-by":"publisher","first-page":"e70012","DOI":"10.1002\/gin2.70012","volume":"2","author":"SK Nagraj","year":"2025","unstructured":"Nagraj SK, Hafver TL, Hohlfeld A, Effa E, Mabetha D, Kunje G, et al. Dissemination strategies of clinical practice guidelines-mixed methods evidence synthesis protocol. Clin Public Health Guidel. 2025;2(2):e70012.","journal-title":"Clin Public Health Guidel"},{"issue":"704","key":"3098_CR34","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.3399\/bjgp20X714029","volume":"71","author":"A Gopfert","year":"2021","unstructured":"Gopfert A, Deeny SR, Fisher R, Stafford M. Primary care consultation length by deprivation and multimorbidity in England: an observational study using electronic patient records. Br J Gen Pract. 2021;71(704):e185\u201392.","journal-title":"Br J Gen Pract"},{"key":"3098_CR35","doi-asserted-by":"publisher","first-page":"h176","DOI":"10.1136\/bmj.h176","volume":"350","author":"E Wallace","year":"2015","unstructured":"Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176.","journal-title":"BMJ"},{"key":"3098_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12875-016-0490-3","volume":"17","author":"B Austad","year":"2016","unstructured":"Austad B, Hetlevik I, Mj\u00f8lstad BP, Helvik AS. Applying clinical guidelines in general practice: a qualitative study of potential complications. BMC Fam Pract. 2016;17:92.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"3098_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41746-022-00557-1","volume":"5","author":"JS Marwaha","year":"2022","unstructured":"Marwaha JS, Landman AB, Brat GA, Dunn T, Gordon WJ. Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation. NPJ Digit Med. 2022;5(1):13.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"3098_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41746-023-00899-4","volume":"6","author":"IJ Borges do Nascimento","year":"2023","unstructured":"Borges do Nascimento IJ, Abdulazeem H, Vasanthan LT, Martinez EZ, Zucoloto ML, \u00d8stengaard L, et al. Barriers and facilitators to utilizing digital health technologies by healthcare professionals. NPJ Digit Med. 2023;6(1):161.","journal-title":"NPJ Digit Med"},{"key":"3098_CR39","doi-asserted-by":"publisher","first-page":"108870","DOI":"10.1016\/j.diabres.2021.108870","volume":"177","author":"N Marx","year":"2021","unstructured":"Marx N, Ryden L, Brosius F, Ceriello A, Cheung M, Cosentino F, et al. Towards living guidelines on cardiorenal outcomes in diabetes: a pilot project of the Taskforce of the Guideline Workshop 2020. Diabetes Res Clin Pract. 2021;177:108870.","journal-title":"Diabetes Res Clin Pract"},{"key":"3098_CR40","unstructured":"Foundation MEE. MAGICapp 2013 [Available from: https:\/\/app.magicapp.org\/#\/guidelines, accessed on 2025 Nov 25]."},{"issue":"7","key":"3098_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamacardio.2023.1266","volume":"8","author":"JB Pierce","year":"2023","unstructured":"Pierce JB, Vaduganathan M, Fonarow GC, Ikeaba U, Chiswell K, Butler J, et al. Contemporary use of sodium-glucose cotransporter-2 inhibitor therapy among patients hospitalized for heart failure with reduced ejection fraction in the US: the get with the guidelines-heart failure registry. JAMA Cardiol. 2023;8(7):652\u201361.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"3098_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","volume":"7","author":"BL Neuen","year":"2019","unstructured":"Neuen BL, Young T, Heerspink HJL, Neal B, Perkovic V, Billot L, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845\u201354.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"3098_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s13300-019-00744-6","volume":"11","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Tentolouris N, Caballero Mateos I, Bellido Casta\u00f1eda V, Morales Portillo C. A multinational real-world study on the clinical characteristics of patients with type 2 diabetes initiating dapagliflozin in Southern Europe. Diabetes Ther. 2020;11(2):423\u201336.","journal-title":"Diabetes Ther"},{"issue":"8","key":"3098_CR44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00592-024-02276-3","volume":"61","author":"PA Cortesi","year":"2024","unstructured":"Cortesi PA, Antonazzo IC, Palladino P, Gnesi M, Mele S, D\u2019Amelio M, et al. Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. Acta Diabetol. 2024;61(8):1017\u201328.","journal-title":"Acta Diabetol"},{"key":"3098_CR45","doi-asserted-by":"publisher","first-page":"215013272110036","DOI":"10.1177\/21501327211003683","volume":"12","author":"EA Christofides","year":"2021","unstructured":"Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Community Health. 2021;12:21501327211003684.","journal-title":"J Prim Care Community Health"},{"issue":"8","key":"3098_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.7326\/0003-4819-157-8-201210160-00533","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA. Screening for chronic kidney disease: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(8):567\u201370.","journal-title":"Ann Intern Med"},{"key":"3098_CR47","unstructured":"(USPSTF) USPSTF. Chronic Kidney Disease: Screening 2025 [Available from: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/chronic-kidney-disease-ckd-screening; https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/draft-update-summary\/chronic-kidney-disease-screening; accessed on 2025 Nov 25]."},{"issue":"8","key":"3098_CR48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2337\/dc24-2746","volume":"48","author":"D Zhang","year":"2025","unstructured":"Zhang D, Gencerliler N, Mukhopadhyay A, Blecker S, Grams ME, Wright DR, et al. Association of patient cost sharing with adherence to GLP-1RA and adverse health outcomes. Diabetes Care. 2025;48(8):1329\u201336.","journal-title":"Diabetes Care"},{"issue":"10","key":"3098_CR49","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1111\/dom.16619","volume":"27","author":"NS Klepser","year":"2025","unstructured":"Klepser NS, Weber ES, Li L, Fleischmann KE, Masharani U, Park M, et al. Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetes. Diabetes Obes Metab. 2025;27(10):5683\u201393.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"3098_CR50","doi-asserted-by":"publisher","first-page":"e2317886","DOI":"10.1001\/jamanetworkopen.2023.17886","volume":"6","author":"J Luo","year":"2023","unstructured":"Luo J, Feldman R, Callaway Kim K, Rothenberger S, Korytkowski M, Hernandez I, et al. Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease. JAMA Netw Open. 2023;6(6):e2317886.","journal-title":"JAMA Netw Open"},{"key":"3098_CR51","doi-asserted-by":"publisher","first-page":"104681","DOI":"10.1016\/j.healthpol.2022.11.002","volume":"134","author":"IR Joosse","year":"2023","unstructured":"Joosse IR, Tordrup D, Glanville J, Kotas E, Mantel-Teeuwisse AK, van den Ham HA. Evidence on the effectiveness of policies promoting price transparency - a systematic review. Health Policy. 2023;134:104681.","journal-title":"Health Policy"},{"key":"3098_CR52","unstructured":"(WHO) WHO. WHO Guidelines Approved by the Guidelines Review Committee. WHO guideline on country pharmaceutical pricing policies. Geneva: World Health Organization, \u00a9 World Health Organization 2020. 2020."},{"issue":"10","key":"3098_CR53","doi-asserted-by":"publisher","first-page":"e25153","DOI":"10.1371\/journal.pone.0025153","volume":"6","author":"SL Norris","year":"2011","unstructured":"Norris SL, Holmer HK, Ogden LA, Burda BU. Conflict of interest in clinical practice guideline development: a systematic review. PLoS ONE. 2011;6(10):e25153.","journal-title":"PLoS ONE"},{"key":"3098_CR54","unstructured":"Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice G. Clinical Practice Guidelines We Can Trust In: Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US), Copyright 2011 by the National Academy of Sciences. All rights reserved. 2011."},{"key":"3098_CR55","doi-asserted-by":"publisher","first-page":"e072953","DOI":"10.1136\/bmj-2022-072953","volume":"380","author":"M Johansson","year":"2023","unstructured":"Johansson M, Guyatt G, Montori V. Guidelines should consider clinicians\u2019 time needed to treat. BMJ. 2023;380:e072953.","journal-title":"BMJ"},{"key":"3098_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","volume":"81","author":"HJ Sch\u00fcnemann","year":"2017","unstructured":"Sch\u00fcnemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, et al. GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017;81:101\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3098_CR57","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13104-016-2244-7","volume":"9","author":"JM Dizon","year":"2016","unstructured":"Dizon JM, Machingaidze S, Grimmer K. To adopt, to adapt, or to contextualise? The big question in clinical practice guideline development. BMC Res Notes. 2016;9(1):442.","journal-title":"BMC Res Notes"},{"issue":"3","key":"3098_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.athoracsur.2024.11.011","volume":"119","author":"V Dayan","year":"2025","unstructured":"Dayan V, Sabik JF 3rd, Ono M, Ruel M, Wan S, Svensson LG, et al. Multisociety endorsement of the 2024 European guideline recommendations on coronary revascularization. Ann Thorac Surg. 2025;119(3):535\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"3098_CR59","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.121.054602","volume":"146","author":"PK Whelton","year":"2022","unstructured":"Whelton PK, Carey RM, Mancia G, Kreutz R, Bundy JD, Williams B. Harmonization of the American College of Cardiology\/American Heart Association and European Society of Cardiology\/European Society of Hypertension Blood Pressure\/Hypertension Guidelines: comparisons, reflections, and recommendations. Circulation. 2022;146(11):868\u201377.","journal-title":"Circulation"},{"issue":"12","key":"3098_CR60","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45(12):3075\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"3098_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12961-022-00899-y","volume":"20","author":"K Saluja","year":"2022","unstructured":"Saluja K, Reddy KS, Wang Q, Zhu Y, Li Y, Chu X, et al. Improving WHO\u2019s understanding of WHO guideline uptake and use in Member States: a scoping review. Health Res Policy Syst. 2022;20(1):98.","journal-title":"Health Res Policy Syst"},{"issue":"7","key":"3098_CR62","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/eurheartj\/ehac606","volume":"44","author":"WB van Dijk","year":"2023","unstructured":"van Dijk WB, Schuit E, van der Graaf R, Groenwold RHH, Laurijssen S, Casadei B, et al. Applicability of European Society of Cardiology guidelines according to gross national income. Eur Heart J. 2023;44(7):598\u2013607.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"3098_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11606-015-3567-0","volume":"31","author":"KK Kondo","year":"2016","unstructured":"Kondo KK, Damberg CL, Mendelson A, Motu\u2019apuaka M, Freeman M, O\u2019Neil M, et al. Implementation processes and pay for performance in healthcare: a systematic review. J Gen Intern Med. 2016;31(Suppl 1):61\u20139.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"3098_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.7326\/M16-1881","volume":"166","author":"AB Mendelson","year":"2017","unstructured":"Mendelson AB, Kondo K, Damberg C, Low A, Mot\u00faapuaka M, Freeman M, et al. The effects of pay-for-performance programs on health, health care use, and processes of care. Ann Intern Med. 2017;166(5):341\u201353.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3098_CR65","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jacc.2024.05.057","volume":"84","author":"JI Shin","year":"2024","unstructured":"Shin JI, Xu Y, Chang AR, Carrero JJ, Flaherty CM, Mukhopadhyay A, et al. Prescription patterns for sodium-glucose cotransporter 2 inhibitors in U.S. health\u00a0systems. J Am Coll Cardiol. 2024;84(8):683\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3098_CR66","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1177\/0272989X11424401","volume":"31","author":"F L\u00e9gar\u00e9","year":"2011","unstructured":"L\u00e9gar\u00e9 F, Boivin A, van der Weijden T, Pakenham C, Burgers J, L\u00e9gar\u00e9 J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Decis Making. 2011;31(6):E45-74.","journal-title":"Med Decis Making"},{"issue":"5","key":"3098_CR67","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/hex.13099","volume":"23","author":"C Kim","year":"2020","unstructured":"Kim C, Armstrong MJ, Berta WB, Gagliardi AR. How to identify, incorporate and report patient preferences in clinical guidelines: a scoping review. Health Expect. 2020;23(5):1028\u201336.","journal-title":"Health Expect"},{"issue":"1","key":"3098_CR68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12913-022-07816-7","volume":"22","author":"DM Thompson","year":"2022","unstructured":"Thompson DM, Booth L, Moore D, Mathers J. Peer support for people with chronic conditions: a systematic review of reviews. BMC Health Serv Res. 2022;22(1):427.","journal-title":"BMC Health Serv Res"},{"key":"3098_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13012-016-0389-3","volume":"11","author":"AR Gagliardi","year":"2016","unstructured":"Gagliardi AR, L\u00e9gar\u00e9 F, Brouwers MC, Webster F, Badley E, Straus S. Patient-mediated knowledge translation (PKT) interventions for clinical encounters: a systematic review. Implement Sci. 2016;11:26.","journal-title":"Implement Sci"},{"issue":"1","key":"3098_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12875-024-02388-3","volume":"25","author":"C Fernandes","year":"2024","unstructured":"Fernandes C, Campbell-Scherer D, Lofters A, Grunfeld E, Aubrey-Bassler K, Cheung H, et al. Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care. BMC Prim Care. 2024;25(1):153.","journal-title":"BMC Prim Care"},{"key":"3098_CR71","doi-asserted-by":"publisher","first-page":"215013272091626","DOI":"10.1177\/2150132720916263","volume":"11","author":"S Peters","year":"2020","unstructured":"Peters S, Bussi\u00e8res A, Depreitere B, Vanholle S, Cristens J, Vermandere M, et al. Facilitating guideline implementation in primary health care practices. J Prim Care Community Health. 2020;11:2150132720916263.","journal-title":"J Prim Care Community Health"},{"key":"3098_CR72","unstructured":"European Society of Cardiology (ESC). ESC Clinical Practice Guidelines endorsement and translation by National Cardiac Societies: European Society of Cardiology (ESC) 2025 [Available from: https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Guidelines-and-National-Cardiac-Societies\/National-Societies-Guidelines-Endorsement, accessed on 2025 Aug 14]."},{"key":"3098_CR73","unstructured":"European Society of Cardiology (ESC). Cardiovascular Round Table (CRT): Implementation of Guidelines at National Level 2025 [Available from: https:\/\/www.escardio.org\/The-ESC\/What-we-do\/Cardiovascular-Round-Table-(CRT)\/Events\/guidelines-implementation-follow-up, accessed on 2025 Sep 09]."},{"key":"3098_CR74","unstructured":"European Society of Cardiology (ESC). Council for Cardiology Practice 2025 [Available from: https:\/\/www.escardio.org\/Councils\/Council-for-Cardiology-Practice-(CCP), accessed on 2025 Sep 09]."},{"issue":"11","key":"3098_CR75","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987\u20131003.","journal-title":"Eur Heart J"},{"key":"3098_CR76","doi-asserted-by":"publisher","first-page":"1509240","DOI":"10.3389\/fcvm.2024.1509240","volume":"11","author":"M Fontainhas","year":"2024","unstructured":"Fontainhas M, Gavina C, Miranda J, Pereira-Silva R, Guichard J, Seixas D, et al. Cardiovascular risk profile with SCORE2 and SCORE2-OP: comparing Portugal, Spain, Italy, and France using the new European predictive models. Front Cardiovasc Med. 2024;11:1509240.","journal-title":"Front Cardiovasc Med."},{"key":"3098_CR77","unstructured":"(ESC) ESoC. HeartScore\u00ae: Calculate the 10-year risk of fatal and non-fatal cardiovascular disease events of your patients 2025 [Available from: https:\/\/www.escardio.org\/Education\/Practice-Tools\/CVD-prevention-toolbox\/HeartScore, accessed on 2025 Sep 09]."},{"key":"3098_CR78","unstructured":"European Society of Cardiology (ESC). CVD Prevention Toolbox: Risk assessment and management tools for health professionals and policy makers 2025 [Available from: https:\/\/www.escardio.org\/Education\/Practice-Tools\/CVD-prevention-toolbox, accessed on 2025 Nov 25]."},{"key":"3098_CR79","doi-asserted-by":"crossref","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Stephen Kaptoge, Helena Bleken \u00d8stergaard, Stephanie H Read, Fabrizio Carinci, Josep Franch-Nadal, Carmen Petitjean, Owen Taylor, Steven H J Hageman, Zhe Xu, Fanchao Shi, Sarah Spackman, Stefano Gualdi, Naomi Holman, Rui Bebiano Da Providencia E Costa, Fabrice Bonnet, Hermann Brenner, Richard F Gillum, Stefan Kiechl, Deborah A Lawlor, Louis Potier, Ben Sch\u00f6ttker, Reecha Sofat, Henry V\u00f6lzke, Johann Willeit, Zane Baltane, Stephen Fava, Sandor Janos, Astrid Lavens, Santa Pildava, Tamara Poljicanin, Ivan Pristas, Peter Rossing, Reiff Sascha, Christa Scheidt-Nave, Iztok Stotl, Gail Tibor, Vilma Urban\u010di\u010d-Rovan, An-Sofie Vanherwegen, Dorte Vistisen, Yong Du, Matthew R Walker, Peter Willeit, Brian Ference, Dirk De Bacquer, Martin Halle, Radu Huculeci, John William McEvoy, Adam Timmis, Panagiotis Vardas, Jannick A N Dorresteijn, Ian Graham, Angela Wood, Bj\u00f6rn Eliasson, William Herrington, John Danesh, D\u00eddac Mauricio, Massimo Massi Benedetti, Naveed Sattar, Frank L J Visseren, Sarah Wild, Emanuele Di Angelantonio, Beverley Balkau, Frederic Fumeron, Hannah Stocker, Bernd Holleczek, Sabine Schipf, Carsten Oliver Schmidt, Marcus D\u00f6rr, Herbert Tilg, Christoph Leitner, Marlene Notdurfter, Julie Taylor, Caroline Dale, David Prieto-Merino, Tamara Buble, Pero Ivanko, Bendix Carstensen, Christin Heidemann, Tibor Gall, Janos Sandor, Jana Lepiksone, Caroline J Magri, Joseph Azzopardi, Jordi Real, Bogdan Vlacho, Manel Mata-Cases. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023;44(28):2544\u201356.","DOI":"10.1093\/eurheartj\/ehad260"},{"key":"3098_CR80","unstructured":"European Society of Cardiology (ESC). ESC CHAT - Your Guidelines Companion https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Guidelines-derivative-products\/Chat2025 [Available from: https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Guidelines-derivative-products\/Chat, accessed on 2025 Nov 25]."},{"key":"3098_CR81","unstructured":"European Society of Cardiology (ESC). Patient versions of ESC Guidelines, European Society of Cardiology; 2023 [Available from: https:\/\/www.escardio.org\/Guidelines\/guidelines-for-patients, accessed on 2025 Nov 25]."},{"issue":"5 Suppl","key":"3098_CR82","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.ahj.2004.09.015","volume":"148","author":"LA Smaha","year":"2004","unstructured":"Smaha LA. The American Heart Association Get With The Guidelines program. Am Heart J. 2004;148(5 Suppl):S46\u20138.","journal-title":"Am Heart J"},{"issue":"1","key":"3098_CR83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCOUTCOMES.110.959122","volume":"5","author":"PA Heidenreich","year":"2012","unstructured":"Heidenreich PA, Hernandez AF, Yancy CW, Liang L, Peterson ED, Fonarow GC. Get with the guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure. Circ Cardiovasc Qual Outcomes. 2012;5(1):37\u201343.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3098_CR84","doi-asserted-by":"publisher","first-page":"101347","DOI":"10.1016\/j.lanepe.2025.101347","volume":"54","author":"CJ Ferro","year":"2025","unstructured":"Ferro CJ, Wanner C, Luyckx V, Fontana M, Gallego D, Vanholder R, et al. A call for urgent action on chronic kidney disease across Europe. Lancet Regional Health. 2025;54:101347.","journal-title":"Lancet Regional Health"},{"issue":"9","key":"3098_CR85","first-page":"CD012472","volume":"9","author":"MS F\u00f8nhus","year":"2018","unstructured":"F\u00f8nhus MS, Dalsb\u00f8 TK, Johansen M, Fretheim A, Skirbekk H, Flottorp SA. Patient-mediated interventions to improve professional practice. Cochrane Database Syst Rev. 2018;9(9):CD012472.","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"3098_CR86","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2023.2854","volume":"329","author":"NJ Pagidipati","year":"2023","unstructured":"Pagidipati NJ, Nelson AJ, Kaltenbach LA, Leyva M, McGuire DK, Pop-Busui R, et al. Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial. JAMA. 2023;329(15):1261\u201370.","journal-title":"JAMA"},{"key":"3098_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s12181-025-00755-7","author":"J Mehilli","year":"2025","unstructured":"Mehilli J, Rudolph T, Wassmann S, Gaede L, Borger MA, Achenbach S, et al. DGK-Kommentar zu den Leitlinien der ESC (2024) zum chronischen Koronarsyndrom. Kardiologie. 2025. https:\/\/doi.org\/10.1007\/s12181-025-00755-7.","journal-title":"Kardiologie"},{"issue":"4","key":"3098_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12181-025-00749-5","volume":"19","author":"RB Schnabel","year":"2025","unstructured":"Schnabel RB, Gunawardene MA, Perings CA, Steven D, Busch H-J, Deisenhofer I, et al. DGK-Kommentar zu den Leitlinien der ESC (2024) zum Management von Vorhofflimmern. Die Kardiologie. 2025;19(4):285\u201394.","journal-title":"Die Kardiologie"},{"issue":"3","key":"3098_CR89","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12181-025-00748-6","volume":"19","author":"U Kintscher","year":"2025","unstructured":"Kintscher U, Halbach M, Berrisch-Rahmel S, Genth-Zotz S, Weil J, Mahfoud F. DGK-Kommentar zu den Leitlinien der ESC (2024) f\u00fcr die Behandlung von erh\u00f6htem Blutdruck und Hypertonie. Dtsch Z Kardiol. 2025;19(3):206\u201314.","journal-title":"Dtsch Z Kardiol"},{"key":"3098_CR90","unstructured":"International Society of Nephrology (ISN), Kidney Disease: Improving Global Outcomes (KDIGO), World Organization of Family Doctors Europe (WONCA Europe), (PCDE) PCDE. Chronic Kidney Disease (CKD): Early Identification and Intervention in Primary Care: International Society of Nephrology (ISN); 2022 [Available from: https:\/\/www.theisn.org\/wp-content\/uploads\/media\/pcp\/PCPOnePage_1Side_English.pdf, accessed on 2025 Nov 25]."},{"issue":"17","key":"3098_CR91","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJMra2403308","volume":"393","author":"L Castera","year":"2025","unstructured":"Castera L, Rinella ME, Tsochatzis EA. Noninvasive assessment of liver fibrosis. N Engl J Med. 2025;393(17):1715\u201329.","journal-title":"N Engl J Med"},{"issue":"5","key":"3098_CR92","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","volume":"169","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Zelber-Sagi S, Lazarus JV, Wong VW, Yilmaz Y, Duseja A, et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis. Gastroenterology. 2025;169(5):1017-32.e2.","journal-title":"Gastroenterology"},{"key":"3098_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y","volume":"3","author":"RT Sutton","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17.","journal-title":"NPJ Digit Med"},{"key":"3098_CR94","doi-asserted-by":"publisher","first-page":"102324","DOI":"10.1016\/j.artmed.2022.102324","volume":"129","author":"E Shalom","year":"2022","unstructured":"Shalom E, Goldstein A, Ariel E, Sheinberger M, Jones V, Van Schooten B, et al. Distributed application of guideline-based decision support through mobile devices: implementation and evaluation. Artif Intell Med. 2022;129:102324.","journal-title":"Artif Intell Med"},{"key":"3098_CR95","unstructured":"Osheroff J, Teich J, Levick D, Saldana L, Velasco F, Sittig D, Rogers K, Jenders R. Improving Outcomes with Clinical Decision Support: An Implementer\u2019s Guide: Healthcare Information and Management Systems Society (HIMSS); 2012."},{"issue":"2","key":"3098_CR96","first-page":"141","volume":"14","author":"JA Osheroff","year":"2007","unstructured":"Osheroff JA, Teich JM, Middleton B, Steen EB, Wright A, Detmer DE. A roadmap for national action on clinical decision support. JAMIA. 2007;14(2):141\u20135.","journal-title":"JAMIA"},{"key":"3098_CR97","doi-asserted-by":"crossref","unstructured":"Forsetlund L, O\u2019Brien MA, Fors\u00e9n L, Mwai L, Reinar LM, Okwen MP, et al. Continuing education meetings and workshops: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2021(9):CD003030.","DOI":"10.1002\/14651858.CD003030.pub3"},{"key":"3098_CR98","doi-asserted-by":"crossref","unstructured":"Ivers N, Yogasingam S, Lacroix M, Brown KA, Antony J, Soobiah C, et al. Audit and feedback: effects on professional practice. Cochrane Database of Syst Rev. 2025:3:CD000259.","DOI":"10.1002\/14651858.CD000259.pub4"},{"key":"3098_CR99","unstructured":"(ESC) ESoC. EuroAspire VI https:\/\/www.escardio.org\/Research\/registries\/global-registries-and-surveys-programme\/euroaspire-vi: European Society of Cardiology (ESC); [Available from: https:\/\/www.escardio.org\/Research\/registries\/global-registries-and-surveys-programme\/euroaspire-vi, accessed on 2025 Nov 10]."},{"issue":"39","key":"3098_CR100","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1093\/eurheartj\/ehae558","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, et al. Variation in secondary prevention of coronary heart disease: the INTERASPIRE study. Eur Heart J. 2024;45(39):4184\u201396.","journal-title":"Eur Heart J"},{"issue":"1","key":"3098_CR101","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13012-018-0774-1","volume":"13","author":"BR Garner","year":"2018","unstructured":"Garner BR, Lwin AK, Strickler GK, Hunter BD, Shepard DS. Pay-for-performance as a cost-effective implementation strategy: results from a cluster randomized trial. Implement Sci. 2018;13(1):92.","journal-title":"Implement Sci"},{"issue":"20","key":"3098_CR102","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","volume":"96","author":"T Jernberg","year":"2010","unstructured":"Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, et al. The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96(20):1617\u201321.","journal-title":"Heart"},{"issue":"10464","key":"3098_CR103","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(24)02227-X","volume":"404","author":"D Erlinge","year":"2024","unstructured":"Erlinge D, Andersson J, Fr\u00f6bert O, T\u00f6rnerud M, Hamid M, Kellerth T, et al. Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial. Lancet. 2024;404(10464):1750\u20139.","journal-title":"Lancet"},{"key":"3098_CR104","doi-asserted-by":"publisher","first-page":"111219","DOI":"10.1016\/j.jclinepi.2023.11.009","volume":"165","author":"S Sayfi","year":"2024","unstructured":"Sayfi S, Charide R, Elliott SA, Hartling L, Munan M, Stallwood L, et al. A multimethods randomized trial found that plain language versions improved adults understanding of health recommendations. J Clin Epidemiol. 2024;165:111219.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3098_CR105","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13012-018-0745-6","volume":"13","author":"MJ Armstrong","year":"2018","unstructured":"Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR. Impact of patient involvement on clinical practice guideline development: a parallel group study. Implement Sci. 2018;13(1):55.","journal-title":"Implement Sci"},{"issue":"42 Suppl","key":"3098_CR106","first-page":"1","volume":"10","author":"CM Concert","year":"2012","unstructured":"Concert CM, Burke RE, Eusebio AM, Slavin EA, Shortridge-Baggett LM. The effectiveness of motivational interviewing on glycemic control for adults with type 2 diabetes mellitus (DM2): a systematic review. JBI Libr Syst Rev. 2012;10(42 Suppl):1\u201317.","journal-title":"JBI Libr Syst Rev"},{"issue":"6","key":"3098_CR107","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.pec.2015.11.003","volume":"99","author":"CA Chrvala","year":"2016","unstructured":"Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926\u201343.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"3098_CR108","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-024-02550-2","volume":"24","author":"K Barnard-Kelly","year":"2025","unstructured":"Barnard-Kelly K, Battelino T, Brosius FC, Ceriello A, Cosentino F, Gavin JR 3rd, et al. Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines\u2014perspectives of the taskforce of the Guideline Workshop. Cardiovasc Diabetol. 2025;24(1):68.","journal-title":"Cardiovasc Diabetol"},{"key":"3098_CR109","unstructured":"Guideline implementation: best practice model for Germany still lacking [press release]. IQWIG 2016 [Available from: https:\/\/www.iqwig.de\/en\/presse\/press-releases\/press-releases-detailpage_10429.html, accessed on 2025 Sep 29]."},{"issue":"1","key":"3098_CR110","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13012-024-01389-1","volume":"19","author":"N de Freitas Mello","year":"2024","unstructured":"de Freitas Mello N, Nascimento Silva S, Gomes DF, da Motta Girardi J, Barreto JOM. Models and frameworks for assessing the implementation of clinical practice guidelines: a systematic review. Implement Sci. 2024;19(1):59.","journal-title":"Implement Sci"},{"issue":"1","key":"3098_CR111","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","volume":"20","author":"VC Pereira","year":"2022","unstructured":"Pereira VC, Silva SN, Carvalho VKS, Zanghelini F, Barreto JOM. Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews. Health Res Policy Syst. 2022;20(1):13.","journal-title":"Health Res Policy Syst"},{"issue":"4","key":"3098_CR112","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.ajkd.2025.01.006","volume":"85","author":"A Ghimire","year":"2025","unstructured":"Ghimire A, Wanner C, Tonelli M. Closing CKD treatment gaps: why practice guidelines and better drug coverage are not enough. Am J Kidney Dis. 2025;85(4):406\u20138.","journal-title":"Am J Kidney Dis"},{"key":"3098_CR113","doi-asserted-by":"crossref","first-page":"f6753","DOI":"10.1136\/bmj.f7086","volume":"347","author":"DH Peters","year":"2013","unstructured":"Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013;347:f6753.","journal-title":"BMJ"},{"key":"3098_CR114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13012-015-0242-0","volume":"10","author":"P Nilsen","year":"2015","unstructured":"Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53.","journal-title":"Implement Sci"},{"issue":"2","key":"3098_CR115","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03098-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:04:01Z","timestamp":1771855441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03098-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03098-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christoph Wanner received honoraria for steering committee and Adboard participation as well as lecturing from Alexion, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk, Sanofi and Vera Therapeutics. Francesco Cosentino served on the advisory boards of Merck Sharp and Dohme, Bristol Myers Squibb, Pfizer and as a consultant to AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp and Dohme, Novo Nordisk, Neopharmed, Berlin Chemie. Katharine Barnard-Kelly is founder and shareholder at Spotlight-AQ Ltd. Katharine Barnard-Kelly has received research support from Dexcom, Embecta, JDRF, Novo Nordisk and Roche Diabetes Care, and honoraria from Sanofi. Tadej Battelino has served on the advisory boards of Abbott, Boehringer Ingelheim, Dreamed Diabetes, Eli Lilly and Company, Indigo Diabetes, Medtronic, Novo Nordisk, and Sanofi. Tadej Battelino has received speaker\u2019s bureau honoraria from Abbott, Eli Lilly and Company, Medtronic, Novo Nordisk, Roche, and Sanofi. The University Medical Center has received research grant support from Abbott, GluSense, Medtronic, Novo Nordisk, Sandoz, Sanofi, and Zealand Pharma. Matthias Bl\u00fcher received honoraria for lectures and as consultant from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly and Company, MSD, Novo Nordisk, and Sanofi. Helena N. Boll is an employee of Sciarc GmbH. Frank C. Brosius is a consultant for MAKSCIENTIFIC. Luca Busetto has nothing reported. Antonio Ceriello reports consulting and speaking for Abbott, Bayer, Berlin Chemie, Boehringer Ingelheim, Cipla, Hikamar Pharma, Guidotti, Eli Lilly, MSD, Merck, Novo Nordisk, Sanofi, Servier, SUN Pharma. James R. Gavin III has served on the advisory boards of Abbott Diabetes Care and Embecta, and on the speaker\u2019s bureaus of Boehringer Ingelheim and Eli Lilly and Company. Francesco Giorgino has served on the advisory boards of AstraZeneca, Eli Lilly and Company, Novo Nordisk, Roche Diabetes Care, Sanofi and as a consultant to AstraZeneca, Boehringer Ingelheim, LifeScan, Medimmune, Medtronic, Merck Sharp & Dohme, Roche Diabetes Care and Sanofi. FG has also received research support from Eli Lilly and Company and Roche Diabetes Care. Jennifer Green has nothing reported. Linong Ji declares that he has no competing interests. Monika Kellerer has served on advisory boards of Abbott Diabetes Care, AstraZeneca, Bayer AG, Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi. Sue Koob has nothing reported. Nebojsa Lalic declares that he has no competing interests. Nikolaus Marx has received research grants from Boehringer Ingelheim and MSD, speaking fees from Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Eli Lilly and Company, MSD, Novo Nordisk, and Sanofi-Aventis and has served or serves on the advisory board of Amgen, Bayer, BMS, Boehringer Ingelheim, MSD, Novo Nordisk, and Sanofi-Aventis. All honoraria are paid to the Aachen University Hospital. Prashant Nedungadi has nothing reported. Christopher G. Parkin has nothing reported. Helena W. Rodbard provides consulting to Bayer, Endogenex, Gan and Lee, Eli Lilly, Novo Nordisk, Kriya Therapeutics, Skye Bioscience, Pacira, Yonis, and Sanofi. She engages in lecturing on behalf of Eli Lilly. She conducts clinical trials with support from Eli Lilly, Novo Nordisk, and Medtronic\/MiniMed. Lars Ryd\u00e9n declares that he has no competing interests related to this work. Banshi Saboo has nothing reported. Wayne Huey-Herng Sheu has nothing reported. Eberhard Standl reports personal fees from Oxford Diabetes Trials Unit, Bayer, Berlin Chemie, Boehringer Ingelheim, Menarini, Merck Serono, EXCEMED, Novartis, Novo Nordisk, and Sanofi. Frank Tacke\u2019s lab has received research grants (funding to the institution) from AstraZeneca, MSD, Gilead, Agomab; he has received honoraria for consulting or lectures from Gilead, Abbvie, Falk, AstraZeneca, Boehringer, Madrigal, MSD, GSK, Ipsen, Mirum, Novartis, Novo Nordisk, Sanofi. Pinar Topsever served on Advisory Boards of Eli Lilly, AstraZeneca, Boehringer Ingelheim, Abbott and LifeScan, and has served on the speaker\u2019s bureau for AstraZeneca and Novo Nordisk. Pinar Topsever received grant\/research support from PCDE, made possible by corporate sponsorship from AstraZeneca, Eli Lilly, Novo Nordisk, and Roche Diagnostics; the sponsors had no input into the study protocols. Oliver Schnell is founder and CEO at Sciarc GmbH, Baierbrunn, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}